1 February 2018 in Cardiology Clinics
1 January 2020 in Wits Journal of Clinical Medicine
More than 35 million cases and 1 million deaths due to coronavirus disease 2019 (COVID-19) have been reported to date, with case-fatality rates ranging from 2.3% to 7.3%. COVID-19 is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which is related to SARS-CoV-1 and Middle East Respiratory Syndrome (MERS) coronaviruses, which have both caused pandemics in the last 20 years. Similar to SARS-CoV-1 and MERS, SARS-CoV-2 primarily affects the respiratory system. However, it has become evident that COVID-19 is a multisystem infection leading to a variety of symptoms and clinical presentations. Amongst these, COVID-19 has also been associated with a range of cardiovascular system (CVS) manifestations with its attendant morbidity and mortality. Overall, several studies have demonstrated an increased incidence of elevated cardiac troponins, myocardial injury, acute coronary syndromes (ACSs), coagulopathy and cardiac arrhythmia in patients with COVID-19. Furthermore, underlying CVS comorbidities have been found to be important in outcomes among patients infected with SARS-CoV-2. The aim of this review is to summarise the important links between COVID- 19 and the CVS, highlighting currently recommended interventions to improve patient outcomes.
1 March 2023 in Southern African Journal of Anaesthesia and Analgesia
9 April 2026 in Clinical Case Reports
Exercise‐induced left bundle branch block (EI‐LBBB) is a rare phenomenon, particularly in patients without structural heart disease. Its pathophysiology remains poorly understood and there are no defined treatment protocols. We report a 77‐year‐old man with a history of syncope who developed EI‐LBBB during a cardiac stress test, with transient electrocardiographic changes that resolved at rest. Coronary angiography revealed only a mild–moderate (approximately 25%–50%) proximal left anterior descending artery stenosis, and the rest of his cardiac evaluation was unremarkable. The patient was commenced on an aerobic exercise program, and reported symptomatic improvement on follow‐up. Although EI‐LBBB is often linked to underlying structural heart disease and coronary artery disease, it can occur in patients with normal cardiac structure. This report summarizes an approach to evaluation and follow‐up of EI‐LBBB and reviews management strategies described in the literature, including exercise training in selected patients.